85405-03-4 (Butanoyl PAF,Butanoyl PAF)

Butanoyl PAF;1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine;3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-(1-oxobutoxy)-, inner salt, 4-oxide, (R)- (ZCI);Butanoyl-platelet activating factor;C16-04:0 PC, 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine, powder;(R)-2-(Butyryloxy)-3-(hexadecyloxy)propyl (2-(trimethylammonio)ethyl) phosphate;85405-03-4;3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-(1-oxobutoxy)-, inner salt, 4-oxide, (R)-;Q27147786;[(2R)-2-butanoyloxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate;PC(O-16:0/4:0);CHEBI:78368;1-hexadecyl-2-butanoyl-sn-glycero-3-phosphocholine;CS-W020961;PC(o20:0);1-O-hexadecyl-2-butanoyl-sn-glycero-3-phosphocholine;HMS3649A07;1-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine;SCHEMBL436646;(2R)-2-(butyryloxy)-3-(hexadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate;C16-04:0 PC, 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine, chloroform;(R)-2-(Butyryloxy)-3-(hexadecyloxy)propyl(2-(trimethylammonio)ethyl)phosphate;LMGP01020072;

MFCD02259312

UVHUBDICYDPLIO-HHHXNRCGSA-N

1S/C28H58NO7P/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-20-23-33-25-27(36-28(30)21-7-2)26-35-37(31,32)34-24-22-29(3,4)5/h27H,6-26H2,1-5H3/t27-/m1/s1

[C@@H](COCCCCCCCCCCCCCCCC)(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC